These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9330437)

  • 21. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
    Lefièvre L; De Lamirande E; Gagnon C
    J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
    Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
    Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
    Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
    Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF; Shoji M; Brackett NL; Helfman DM
    J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet effects of KW-7, a new inhibitor of cyclic nucleotide phosphodiesterases.
    Wu CC; Wang WY; Kuo RY; Chang FR; Wu YC
    Eur J Pharmacol; 2004 Jan; 483(2-3):187-94. PubMed ID: 14729106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. YC-1, a novel activator of platelet guanylate cyclase.
    Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
    Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide.
    Weisbrod RM; Griswold MC; Yaghoubi M; Komalavilas P; Lincoln TM; Cohen RA
    Br J Pharmacol; 1998 Dec; 125(8):1695-707. PubMed ID: 9886761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Nezu A; Shinoda H; Minami M
    Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of endotoxin-induced cytotoxicity and prostacyclin production in cultured bovine pulmonary artery endothelial cells by phosphodiesterase inhibition.
    Hussein A; Meyrick B; Graber S; Berry L; Brigham KL
    Exp Lung Res; 1988; 14(5):637-54. PubMed ID: 2465143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
    Yamakado T; Tanaka F; Hidaka H
    Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug.
    Catalán RE; Martínez AM; Aragonés MD; Hernández F; Garde E; Lombardía M
    Thromb Res; 1994 Jul; 75(2):121-32. PubMed ID: 7974386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS; Eardley D; Watkins R; Prioli N
    Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA).
    Connolly BJ; Willits PB; Warrington BH; Murray KJ
    Biochem Pharmacol; 1992 Dec; 44(12):2303-6. PubMed ID: 1335252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.
    Kishi Y; Ashikaga T; Watanabe R; Numano F
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):351-7. PubMed ID: 7528289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
    Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
    Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN; Kramer GL
    Mol Cell Endocrinol; 1981 Jul; 23(1):1-9. PubMed ID: 6167475
    [No Abstract]   [Full Text] [Related]  

  • 38. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein.
    Wright IK; Amirchetty-Rao S; Kendall DA
    Br J Pharmacol; 1994 Aug; 112(4):1146-50. PubMed ID: 7524992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
    Tanaka M; Muramatsu M; Aihara H
    Biochem Pharmacol; 1989 Jun; 38(12):1985-91. PubMed ID: 2545208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxation and cyclic GMP levels in response to sildenafil in human pulmonary arteries from donors.
    Mauricio MD; Segarra G; Medina P; Aldasoro M; Martínez-León JB; Vila JM
    Eur J Pharmacol; 2006 Jan; 530(3):259-62. PubMed ID: 16380114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.